Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

Multicenter phase II study of preoperative chemoradiotherapy with CApecitabine plus Temozolomide in patients with MGMT silenced and microsat… Recruiting

2024-513931-26-00 locally advanced rectal cancer (LARC) 4 2021-12-01
STOP-LEUKEMIA: Repurposing metformin as a leukemia-preventive drug in CCUS and LR-MDS Recruiting

2024-518436-37-01 Myelodysplastic syndromes (MDS), very low- and low-risk 4 2021-12-01
A study to investigate the safety and tolerability of Trastuzumab Deruxtecan in combination with Immunotherapy Agents with and without chemo… Recruiting

2023-504949-31-00 Advanced or metastatic non-squamous non-small lung canc 3 2021-12-01
SIOP-HRMB: An international prospective trial on clinically high-risk medulloblastoma (HR-MB) in patients older than 3 years. Recruiting

2024-510578-25-00 Histologically proven high-risk medulloblastoma, with a 5 2021-11-05
HARBOR: Study of BLU-263 for Indolent Systemic Mastocytosis Recruiting

2024-516728-32-00 Indolent Systemic Mastocytosis and SSM 10 2021-10-29
A Randomized & Observational phase II trial comparing the activity of TrabectedIn vs gemCitabine in patients with metastatic or locally adva… Recruiting

2024-513820-40-00 Metastatic or locally advanced leiomyosarcoma 4 2021-10-29
Study to Evaluate the PK and Safety of Oral Decitabine and Cedazuridine in Cancer Patients with Renal Impairment Recruiting

2024-516291-16-00 Acute myeloid lymphoma (AML), myelodysplastic syndrome 3 2021-10-26
A study to assess the safety and tolerability of next-generation neoantigen-selected Tumor-infiltrating Lymphocyte (TIL) therapy. NEXTGEN-TI… Recruiting

2024-517021-12-00 Advanced epithelial tumors and immune checkpoint blocka 3 2021-10-26
Prospective, randomized, open, multicenter Phase II trial to investigate the efficacy of trifluridine/tipiracil plus panitumumab versus trif… Recruiting

2024-513723-16-00 metastatic colorectal cancer 4 2021-10-21
DZR123 (CPI-0209) in Patients with Advanced Solid Tumors and Lymphomas Recruiting

2023-508002-20-00 advanced, solid, relapsed tumors / advanced tumors: hum 7 2021-10-21
A Phase 1/2a, First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of HDP-101 in Patients with Plasma C… Recruiting

2024-515273-10-00 Relapsed or refractory Multiple Myeloma (r/r MM) 7 2021-10-19
A Phase 1/2 Trial of the Synthetic Cannabinoid ART27.13 in Patients with Cancer Anorexia and Weight Loss Recruiting

2024-518177-33-00 Cancer Anorexia 7 2021-10-01
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients with Metastatic Colorectal Cancer (INTRINSIC) Recruiting

2023-505163-37-00 Metastatic Colorectal Cancer 3 2021-10-01
A Study to Evaluate Chemotherapy Plus Osimertinib Against Chemotherapy Plus Placebo in Patients With Non-small Cell Lung Cancer (NSCLC) (COM… Recruiting

2024-516330-35-00 Non-Small Cell Lung Cancer 5 2021-09-29
A Phase 2 Study to Test Effects of Using DAY101 in Children with Brain Cancer Recruiting

2024-510691-20-00 RAF-Altered, Recurrent or Progressive Low-Grade Glioma 4 2021-09-23
OPTIMISE Recruiting

2023-509814-12-00 Colorectal cancer with metastasis 4 2021-09-22
EXTENSION STUDY FOR PATIENTS WHO HAVE COMPLETED A PRIOR GLAXOSMITHKLINE/TESARO-SPONSORED NIRAPARIB STUDY AND ARE JUDGED BY THE INVESTIGATOR … Recruiting

2023-506618-29-00 Advanced ovarian, breast, or prostate cancer 4 2021-09-22
Phase III study comparing Trabectedin (T) versus T plus tTF-NGR to entrap T inside the tumor in patients with metastatic and/or refractory s… Recruiting

2024-516392-33-00 Patients (18-75 years) with metastatic and/or refractor 5 2021-09-17
Ibrutinib and Obinutuzumab as first-line treatment for patients with Chronic Lymphocytic Leukemia Recruiting

2024-514824-18-00 chronic lymphocytic leukemia/small lymphocytic lymphoma 4 2021-09-16
Phase II study on trabectedin in adults and young adults HEY1-NOCA2 positive skeletal and extra-skeletal mesenchymal chondrosarcoma (MCS) Recruiting

2024-514319-85-00 Advanced rearranged mesenchymal chondrosarcoma 4 2021-09-14
Phase II study evaluating the efficacy of Nivolumab in the treatment of patients with nasopharyngeal cancer who progressed during or after p… Recruiting

2024-517479-19-00 Nasopharyngeal Cancer 4 2021-08-26
Mesalamine administration to prevent development of colorectal cancer in Lynch syndrome Recruiting

2024-514765-19-01 Lynch syndrome, which is increasing the risk of develop 4 2021-08-12
Multicentric non-randomized phase II of pembrolizumab in combination with etoposide-cisplatin-based chemotherapy in first-line small cell ov… Recruiting

2024-515310-40-01 Patients with a confirmed diagnosis of ovarian small ce 4 2021-08-04
Beamion LUNG-1: A study to test different doses of zongertinib in people with different types of advanced cancer (solid tumours with changes… Recruiting

2024-511246-39-00 Solid tumours with HER2 aberrations 1 2021-07-27